The pathophysiology of multiple sclerosis (MS) is characterized by demyelination, which culminates in a reduction in axonal transmission. Axonal and neuronal degeneration seem to be concomitant ...
Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...
Hosted on MSN1mon
Multiple sclerosis appears to protect against Alzheimer's diseaseBrier et al, Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients, Annals of Neurology (2024). DOI: 10.1002/ana.27027 ...
Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.
The Multiple Sclerosis Functional Composite (MSFC) reached a worsening inflection point with menopause (slope difference, 0.08) and an increase in serum neurofilament light chain (slope difference, −0 ...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback